Article Information
History
- February 14, 2019.
Article Versions
- Version 1 (February 14, 2019 - 16:51).
- You are currently viewing Version 2 of this article (February 14, 2019 - 22:06).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Charles A. Berdan1,
- Raymond Ho3,
- Haley S. Lehtola1,
- Milton To1,
- Xirui Hu2,
- Tucker R. Huffman2,
- Yana Petri2,
- Chad R. Altobelli2,
- Sasha G. Demeulenaere2,
- James A. Olzmann1,
- Thomas J. Maimone2,* and
- Daniel K. Nomura1,2,3,*
- 1Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720
- 2Department of Chemistry, University of California, Berkeley, Berkeley, CA 94720
- 3Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720
- ↵*correspondence to maimone{at}berkeley.edu and dnomura{at}berkeley.edu
Posted February 14, 2019.
Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells
